Wird geladen...
Harnessing the immune system in glioblastoma
Glioblastoma is the most common primary malignant brain tumour. Survival is poor and improved treatment options are urgently needed. Although immunotherapies have emerged as effective treatments for a number of cancers, translation of these through to brain tumours is a distinct challenge, particula...
Gespeichert in:
| Veröffentlicht in: | Br J Cancer |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251037/ https://ncbi.nlm.nih.gov/pubmed/30393372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0258-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|